This is excellent news for us LT'ers, just wasn't expecting it to be another 6month extention. But that just really goes to show the amount of interest 3M have in this technology. Now there are a few lines in this announcement which have really caught my attention:
'3M has confirmed its interest in working with OBJs current/potential clients in patch development and or CONTRACT MANUFACTURING following tests'
Now with 'encouraging' results its hard to know what they really mean. Do they have other competitors to watch out for? Hence they don't want to attract a flock of new companies? Or was it just above average results? I just don't know.
Also the expansion into new markets seems like excellent news as OBJ can reach into many other multi-national companies with 'faster time to market and lesser regulatory barriers'
In addition the company is 'actively engaged with a number of international companies across a variety of product sectors in the USA, Europe and UK'
and: 'partnering discussions, product evaluation and proof of concept studies are UNDERWAY'
Yep thats right every activity outline above is underway. Don't forget that Glyn had to take his time to refine this announcement so there is no bulls^&%.
So in all over the next 6months we should be able to recieve excellent news regarding all parties involved including partnering and manufactoring update or confirmations. Most definitely worth the hold thats for sure. Very very good announcement in my books. GO OBJ!!!
- Forums
- ASX - By Stock
- WFL
- shareholder update
shareholder update, page-22
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online